Adamis Pharma (ADMP) Stock

DelistedNasdaq: ADMPAdamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease.

0.49
Final close · Nov 9, 2023

ADMP is no longer traded. Adamis Pharma was delisted from the Nasdaq in November 2023.

Prices on this page are historical; the last trade was November 9, 2023 at $0.49.

Adamis Pharma stock price history

Split-adjusted closes, 1995–2023

ADMP final trading statistics

Final close
$0.49
Final trading day
Nov 9, 2023
Market cap at delisting
$4.59M
Shares outstanding
9.36M
Final 52-week range
$0.05 – $8.28
Avg. volume (final 3 mo.)
1,347,104
All-time high (split-adj.)
$1000000.00 · Dec 2008
All-time low (split-adj.)
$0.45 · Sep 2023
Return since IPO
-100.0%
Beta
1.28
Book value / share
-$4.24
Price / book
-0.12
Final 52 wk
0.058.28

Adamis Pharma earnings per share

Earnings per share

Adamis Pharma revenue & net income

RevenueNet income

Adamis Pharma annual financials

Fiscal yearRevenueNet incomeEPS
FY2022$4.76M-$26.2M-$0.18
FY2021$2.21M-$34.6M-$0.45
FY2020$16.53M-$49.4M-$0.62
FY2019$22.11M-$29.3M-$0.55
FY2018$15.09M-$39.0M-$1.01

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Adamis Pharma

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company is headquartered in San Diego, California.

Adamis Pharma stock FAQ

What happened to Adamis Pharma stock?

Adamis Pharma stock was delisted from the Nasdaq. Its final close was $0.49 on November 9, 2023.

Is ADMP stock still trading?

No. ADMP was delisted from the Nasdaq in November 2023 and no longer trades on a U.S. exchange.

What was the last price of ADMP stock?

ADMP closed at $0.49 on its final trading day, November 9, 2023, for a market value of about $4.59M.

What were Adamis Pharma's revenue and earnings in its last full fiscal year?

Adamis Pharma reported revenue of $4.76M and net income of -$26.2M in fiscal 2022, its last full year as a public company.

When did Adamis Pharma go public?

Adamis Pharma stock began trading on August 14, 1995.

Drug Manufacturers - Specialty & Generic stocks to research

All Healthcare stocks →